Continuous 'microdose' isotretinoin in adult recalcitrant rosacea [6]

Clinical and Experimental Dermatology

Volumn 29, Issue 2, 2004, Pages 204-205

  Hofer, T ^a  

^a Private Practice   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; HUMAN; INFORMED CONSENT; LETTER; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RELAPSE; ROSACEA; SAMPLE SIZE; SIDE EFFECT;

ADULT; CHRONIC DISEASE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROSACEA;

EID: 1642273034     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01472.x     Document Type: Letter

References (5)

1. Erdogan FG, Yurtsever P, Aksoy D, Eskiolglu F. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998; 134: 884-5.
2. Palmer RA, Sidhu S, Goodwin PG. 'Microdose' isotretinoin. Br J Dermatol 2000; 143: 205-6.
3. Finlay AY, Khan GK. Dermatology life quality index - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
4. Newton JN, Mallon E, Klassen A et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997; 137: 563-7.
5. Ling TC, Parkin G, Islam J et al. What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH? Br J Dermatol 2001; 144: 630-2.